Avidity Biosciences
RNA
#1882
Rank
NZ$19.04 B
Marketcap
NZ$126.42
Share price
0.07%
Change (1 day)
161.87%
Change (1 year)

Market capitalization of Avidity Biosciences (RNA)

Market cap: NZ$19.04 Billion

As of January 2026 Avidity Biosciences has a market cap of NZ$19.04 Billion. This makes Avidity Biosciences the world's 1882th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Avidity Biosciences from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$19.04 B1.51%
2025NZ$18.76 B194.61%
2024NZ$6.36 B462.18%
2023NZ$1.13 B-51.22%
2022NZ$2.32 B42.33%
2021NZ$1.63 B22.96%
2020NZ$1.32 B

End of Day market cap according to different sources

On Jan 14th, 2026 the market cap of Avidity Biosciences was reported to be:

NZ$19.03 Billion
by Nasdaq info icon info icon
NZ$19.03 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
PTC Therapeutics
PTCT
NZ$10.72 B-43.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
NZ$1.42 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
NZ$4.04 B-78.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
NZ$4.88 B-74.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
NZ$0.21 B-98.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
NZ$19.03 B-0.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$253.10 B 1,228.69%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$174.23 B 814.66%๐Ÿ‡ฌ๐Ÿ‡ง UK